"beta-Lactam Resistance" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Nonsusceptibility of bacteria to the action of the beta-lactam antibiotics. Mechanisms responsible for beta-lactam resistance may be degradation of antibiotics by BETA-LACTAMASES, failure of antibiotics to penetrate, or low-affinity binding of antibiotics to targets.
| Descriptor ID |
D018440
|
| MeSH Number(s) |
G06.099.225.500 G06.225.347.500 G07.690.773.984.269.347.500
|
| Concept/Terms |
beta-Lactam Resistance- beta-Lactam Resistance
- beta Lactam Resistance
- beta-Lactamase Resistant
- Resistant, beta-Lactamase
- beta Lactamase Resistant
- beta-Lactam Resistant
- beta Lactam Resistant
- beta-Lactamase Resistance
- Resistance, beta-Lactamase
- beta Lactamase Resistance
|
Below are MeSH descriptors whose meaning is more general than "beta-Lactam Resistance".
Below are MeSH descriptors whose meaning is more specific than "beta-Lactam Resistance".
This graph shows the total number of publications written about "beta-Lactam Resistance" by people in this website by year, and whether "beta-Lactam Resistance" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 1 | 1 | 2 |
| 2007 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 0 | 2 | 2 |
| 2015 | 3 | 0 | 3 |
| 2016 | 3 | 0 | 3 |
| 2017 | 26 | 17 | 43 |
| 2018 | 12 | 7 | 19 |
| 2019 | 8 | 4 | 12 |
| 2020 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "beta-Lactam Resistance" by people in Profiles.
-
Colonization by multidrug-resistant microorganisms in ICU patients during the COVID-19 pandemic. Med Intensiva (Engl Ed). 2021 Jun-Jul; 45(5):313-315.
-
Streptococcus pyogenes pbp2x Mutation Confers Reduced Susceptibility to ß-Lactam Antibiotics. Clin Infect Dis. 2020 06 24; 71(1):201-204.
-
Carbapenem-sparing strategy: carbapenemase, treatment, and stewardship. Curr Opin Infect Dis. 2019 12; 32(6):663-673.
-
Attributable sources of community-acquired carriage of Escherichia coli containing ß-lactam antibiotic resistance genes: a population-based modelling study. Lancet Planet Health. 2019 08; 3(8):e357-e369.
-
KPC-31 expressed in a ceftazidime/avibactam-resistant Klebsiella pneumoniae is associated with relevant detection issues. J Antimicrob Chemother. 2019 08 01; 74(8):2464-2466.
-
Perioperative prophylaxis with ertapenem reduced infections caused by extended-spectrum betalactamase-producting Enterobacteriaceae after kidney transplantation. BMC Nephrol. 2019 07 22; 20(1):274.
-
Reversal of carbapenemase-producing Klebsiella pneumoniae epidemiology from blaKPC- to blaVIM-harbouring isolates in a Greek ICU after introduction of ceftazidime/avibactam. J Antimicrob Chemother. 2019 07 01; 74(7):2051-2054.
-
ß-lactam resistance genes in bacteriophage and bacterial DNA from wastewater, river water, and irrigation water in Washington State. Water Res. 2019 Sep 15; 161:335-340.
-
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study. J Infect. 2019 08; 79(2):130-138.
-
Role of place of acquisition and inappropriate empirical antibiotic therapy on the outcome of extended-spectrum ß-lactamase-producing Enterobacteriaceae infections. Int J Antimicrob Agents. 2019 Jul; 54(1):49-54.